= 0.40 Inventors with similar research interests:
Years Active: 1995-2015
Title: Thierry Boon-Falleur: Pioneering Innovator in T Lymphocyte Modulation
Introduction: Thierry Boon-Falleur, based in Brussels, BE, is an exceptional innovator and diligent researcher in the field of T lymphocyte modulation. With an impressive portfolio of 141 patents, his contributions to the field have revolutionized our understanding of T lymphocyte activity and its applications in various areas, especially cancer research. In this article, we will explore some of his latest patents, highlight his career achievements, delve into his notable collaborations, and conclude with an appreciation of his significant contributions to the scientific community.
Latest Patents: One of Thierry Boon-Falleur's recent patents is the "Method for Modulating Activity of T Lymphocytes." This invention focuses on the modulation of T lymphocyte activity by changing the distance between two vital T lymphocyte receptors, TCR and CD8. By utilizing modulators that alter the distance between these receptors, this method allows for precise control over T lymphocyte activity, opening up new possibilities in immunotherapy and other medical applications.
Another significant patent is his work on "Tumour Rejection Antigens." Boon-Falleur has developed polypeptides that consist of amino acid sequences capable of complexing with the major histocompatibility complex molecule type HLA-A2, preferably HLA-A2.1. These polypeptides have shown promise in stimulating an effective immune response against tumor cells, potentially contributing to novel cancer treatments.
Career Highlights: Thierry Boon-Falleur has a long and distinguished career, with noteworthy contributions in cancer research. Notably, he has worked with the Ludwig Institute for Cancer Research, a renowned institution focused on improving cancer patient outcomes through scientific research. Boon-Falleur's dedication to pioneering advancements in T lymphocyte modulation has brought him recognition and esteem in the scientific community.
Collaborations: Throughout his career, Thierry Boon-Falleur has had the opportunity to collaborate with esteemed colleagues, including Pierre Van Der Bruggen and Pierre Coulie. These collaborations have resulted in groundbreaking research and the publication of numerous scientific papers, further bolstering Boon-Falleur's reputation as a respected innovator in the field of T lymphocyte modulation.
Conclusion: Thierry Boon-Falleur's contributions to the field of T lymphocyte modulation have been nothing short of groundbreaking. Through his innovative patents, he has demonstrated a deep understanding of T lymphocyte biology and its potential for therapeutic applications. Boon-Falleur's dedication to advancing cancer research, remarkable career achievements, and collaboration with esteemed colleagues exemplify his commitment to scientific progress. We eagerly await further discoveries from this exceptional innovator in the years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.